Press Releases

Preclinical Studies: ANN-102 for Sarcopenia

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy

JUNE 9 2025

Meet Anodyne at JPM Healthcare Week 2025

JANUARY 12 2025

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs

DECEMBER 19 2024

Business Wire

Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MA

OCTOBER 25 2024

Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors.

FEBRUARY 6 2023

Business Wire